• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CXCL6-EGFR 诱导的枯否细胞分泌 TGF-β1 通过 SMAD2/BRD4/C-MYC/EZH2 通路促进肝纤维化中肝星状细胞的活化。

CXCL6-EGFR-induced Kupffer cells secrete TGF-β1 promoting hepatic stellate cell activation via the SMAD2/BRD4/C-MYC/EZH2 pathway in liver fibrosis.

机构信息

Department of Gastroenterology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

出版信息

J Cell Mol Med. 2018 Oct;22(10):5050-5061. doi: 10.1111/jcmm.13787. Epub 2018 Aug 14.

DOI:10.1111/jcmm.13787
PMID:30106235
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6156397/
Abstract

Liver fibrosis is the excessive accumulation of extracellular matrix proteins in response to the inflammatory response that accompanies tissue injury, which at an advanced stage can lead to cirrhosis and even liver failure. This study investigated the role of the CXC chemokine CXCL6 (GCP-2) in liver fibrosis. The expression of CXCL6 was found to be elevated in the serum and liver tissue of high stage liver fibrosis patients. Furthermore, treatment with CXCL6 (100 ng/mL) stimulated the phosphorylation of EGFR and the expression of TGF-β in cultured Kupffer cells (KCs). Although treatment with CXCL6 directly did not activate the hepatic stellate cell (HSC) line, HSC-T6, HSCs cultured with media taken from KCs treated with CXCL6 or TGF-β showed increased expression of α-SMA, a marker of HSC activation. CXCL6 was shown to function via the SMAD2/BRD4/C-MYC/EZH2 pathway by enhancing the SMAD3-BRD4 interaction and promoting direct binding of BRD4 to the C-MYC promoter and CMY-C to the EZH2 promoter, thereby inducing profibrogenic gene expression in HSCs, leading to activation and transdifferentiation into fibrogenic myofibroblasts. These findings were confirmed in a mouse model of CCl -induced chronic liver injury and fibrosis in which the levels of CXCL6 and TGF-β in serum and the expression of α-SMA, SMAD3, BRD4, C-MYC, and EZH2 in liver tissue were increased. Taken together, our results reveal that CXCL6 plays an important role in liver fibrosis through stimulating the release of TGF-β by KCs and thereby activating HSCs.

摘要

肝纤维化是细胞外基质蛋白在组织损伤伴随的炎症反应下过度积累的结果,在晚期可导致肝硬化甚至肝衰竭。本研究探讨了 CXC 趋化因子 CXCL6(GCP-2)在肝纤维化中的作用。研究发现,高阶段肝纤维化患者的血清和肝组织中 CXCL6 的表达升高。此外,CXCL6(100ng/mL)处理刺激了培养的枯否细胞(KCs)中 EGFR 的磷酸化和 TGF-β的表达。虽然 CXCL6 直接处理不能激活肝星状细胞(HSC)系 HSC-T6,但用 CXCL6 或 TGF-β处理的 KCs 培养基培养的 HSCs 显示出 α-SMA 的表达增加,α-SMA 是 HSC 激活的标志物。CXCL6 通过增强 SMAD3-BRD4 相互作用并促进 BRD4 直接结合到 C-MYC 启动子和 CMYC 到 EZH2 启动子,从而在 HSCs 中诱导促纤维化基因表达,导致 HSCs 激活和向成纤维肌纤维母细胞转化,从而发挥作用。这些发现在 CCl 诱导的慢性肝损伤和纤维化小鼠模型中得到了证实,该模型中血清中的 CXCL6 和 TGF-β水平以及肝组织中 α-SMA、SMAD3、BRD4、C-MYC 和 EZH2 的表达均增加。综上所述,我们的研究结果表明,CXCL6 通过刺激 KCs 释放 TGF-β来激活 HSCs,从而在肝纤维化中发挥重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80cc/6156397/48b7765db35d/JCMM-22-5050-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80cc/6156397/1f5c6002a7c1/JCMM-22-5050-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80cc/6156397/f075a00fc335/JCMM-22-5050-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80cc/6156397/a82d0bb7f6e0/JCMM-22-5050-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80cc/6156397/710bb84d8e71/JCMM-22-5050-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80cc/6156397/d0d8aa69eece/JCMM-22-5050-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80cc/6156397/48b7765db35d/JCMM-22-5050-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80cc/6156397/1f5c6002a7c1/JCMM-22-5050-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80cc/6156397/f075a00fc335/JCMM-22-5050-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80cc/6156397/a82d0bb7f6e0/JCMM-22-5050-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80cc/6156397/710bb84d8e71/JCMM-22-5050-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80cc/6156397/d0d8aa69eece/JCMM-22-5050-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80cc/6156397/48b7765db35d/JCMM-22-5050-g006.jpg

相似文献

1
CXCL6-EGFR-induced Kupffer cells secrete TGF-β1 promoting hepatic stellate cell activation via the SMAD2/BRD4/C-MYC/EZH2 pathway in liver fibrosis.CXCL6-EGFR 诱导的枯否细胞分泌 TGF-β1 通过 SMAD2/BRD4/C-MYC/EZH2 通路促进肝纤维化中肝星状细胞的活化。
J Cell Mol Med. 2018 Oct;22(10):5050-5061. doi: 10.1111/jcmm.13787. Epub 2018 Aug 14.
2
NLRC5 regulates TGF-β1-induced proliferation and activation of hepatic stellate cells during hepatic fibrosis.NLRC5在肝纤维化过程中调节转化生长因子-β1诱导的肝星状细胞增殖和激活。
Int J Biochem Cell Biol. 2016 Jan;70:92-104. doi: 10.1016/j.biocel.2015.11.010. Epub 2015 Nov 26.
3
Histone H3K27 methyltransferase EZH2 and demethylase JMJD3 regulate hepatic stellate cells activation and liver fibrosis.组蛋白 H3K27 甲基转移酶 EZH2 和去甲基酶 JMJD3 调节肝星状细胞激活和肝纤维化。
Theranostics. 2021 Jan 1;11(1):361-378. doi: 10.7150/thno.46360. eCollection 2021.
4
Enhancer of Zeste Homologue 2 Inhibition Attenuates TGF-β Dependent Hepatic Stellate Cell Activation and Liver Fibrosis.EZH2 抑制减轻 TGF-β 依赖的肝星状细胞激活和肝纤维化。
Cell Mol Gastroenterol Hepatol. 2019;7(1):197-209. doi: 10.1016/j.jcmgh.2018.09.005. Epub 2018 Sep 15.
5
Gremlin1 Accelerates Hepatic Stellate Cell Activation Through Upregulation of TGF-Beta Expression.Gremlin1通过上调转化生长因子-β表达加速肝星状细胞激活。
DNA Cell Biol. 2017 Jul;36(7):603-610. doi: 10.1089/dna.2017.3707. Epub 2017 May 3.
6
Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling.岩白菜素 D 通过阻断 TGF-β/Smad 和 YAP 信号通路抑制肝星状细胞激活和肝纤维化。
Phytomedicine. 2020 Nov;78:153294. doi: 10.1016/j.phymed.2020.153294. Epub 2020 Jul 28.
7
EZH2-mediated repression of Dkk1 promotes hepatic stellate cell activation and hepatic fibrosis.EZH2 介导的 Dkk1 抑制促进肝星状细胞激活和肝纤维化。
J Cell Mol Med. 2017 Oct;21(10):2317-2328. doi: 10.1111/jcmm.13153. Epub 2017 Mar 23.
8
LEFTY2 alleviates hepatic stellate cell activation and liver fibrosis by regulating the TGF-β1/Smad3 pathway.LEFTY2 通过调节 TGF-β1/Smad3 通路减轻肝星状细胞活化和肝纤维化。
Mol Immunol. 2020 Oct;126:31-39. doi: 10.1016/j.molimm.2020.07.012. Epub 2020 Aug 1.
9
Amygdalin inhibits TGFβ1-induced activation of hepatic stellate cells (HSCs) in vitro and CCl-induced hepatic fibrosis in rats in vivo.苦杏仁苷抑制 TGFβ1 在体外诱导的肝星状细胞(HSCs)活化和 CCl 在体内诱导的大鼠肝纤维化。
Int Immunopharmacol. 2021 Jan;90:107151. doi: 10.1016/j.intimp.2020.107151. Epub 2020 Dec 6.
10
Synergistic anti-liver fibrosis actions of total astragalus saponins and glycyrrhizic acid via TGF-β1/Smads signaling pathway modulation.黄芪总皂苷与甘草酸通过调节TGF-β1/Smads信号通路协同发挥抗肝纤维化作用。
J Ethnopharmacol. 2016 Aug 22;190:83-90. doi: 10.1016/j.jep.2016.06.011. Epub 2016 Jun 6.

引用本文的文献

1
Dynamic crosstalk between HSCs and liver microenvironment: multicellular interactions in the regulation of liver fibrosis.肝星状细胞与肝脏微环境之间的动态串扰:肝脏纤维化调控中的多细胞相互作用
Front Cell Dev Biol. 2025 Jul 21;13:1635763. doi: 10.3389/fcell.2025.1635763. eCollection 2025.
2
Myeloid cells in chronic liver inflammation.慢性肝脏炎症中的髓样细胞。
Cell Mol Immunol. 2025 Jul 28. doi: 10.1038/s41423-025-01324-4.
3
Integrated machine learning and single-cell RNA sequencing reveal COL4A2 and CXCL6 as oxidative stress-associated biomarkers in periodontitis.

本文引用的文献

1
Coordinate activities of BRD4 and CDK9 in the transcriptional elongation complex are required for TGFβ-induced Nox4 expression and myofibroblast transdifferentiation.转录延伸复合物中BRD4和CDK9的协同活性是TGFβ诱导Nox4表达和成肌纤维细胞转分化所必需的。
Cell Death Dis. 2017 Feb 9;8(2):e2606. doi: 10.1038/cddis.2016.434.
2
BRD4 Regulates EZH2 Transcription through Upregulation of C-MYC and Represents a Novel Therapeutic Target in Bladder Cancer.BRD4通过上调C-MYC来调节EZH2转录,是膀胱癌中的一个新型治疗靶点。
Mol Cancer Ther. 2016 May;15(5):1029-42. doi: 10.1158/1535-7163.MCT-15-0750. Epub 2016 Mar 3.
3
整合机器学习和单细胞RNA测序揭示COL4A2和CXCL6作为牙周炎中氧化应激相关生物标志物。
Front Immunol. 2025 Jun 5;16:1598642. doi: 10.3389/fimmu.2025.1598642. eCollection 2025.
4
Single-cell transcription reveals hepatocyte-to-cholangiocyte reprogramming and biliary gene profile in biliary atresia.单细胞转录揭示了胆道闭锁中肝细胞向胆管细胞的重编程及胆管基因谱。
Hepatol Commun. 2025 May 6;9(5). doi: 10.1097/HC9.0000000000000710. eCollection 2025 May 1.
5
Diagnostic and clinical relevance of targeted metabolomic analysis of serum bile acid profiles in acute pancreatitis.急性胰腺炎血清胆汁酸谱靶向代谢组学分析的诊断及临床意义
BMC Gastroenterol. 2025 Mar 18;25(1):181. doi: 10.1186/s12876-025-03714-4.
6
Key role of macrophages in the progression of hepatic fibrosis.巨噬细胞在肝纤维化进展中的关键作用。
Hepatol Commun. 2024 Dec 11;9(1). doi: 10.1097/HC9.0000000000000602. eCollection 2025 Jan 1.
7
The role of macrophages in liver fibrosis: composition, heterogeneity, and therapeutic strategies.巨噬细胞在肝纤维化中的作用:组成、异质性及治疗策略
Front Immunol. 2024 Nov 20;15:1494250. doi: 10.3389/fimmu.2024.1494250. eCollection 2024.
8
Proteomic Characterization of Corneal Epithelial and Stromal Cell-Derived Extracellular Vesicles.角膜上皮和基质细胞衍生细胞外囊泡的蛋白质组学特征。
Int J Mol Sci. 2024 Sep 26;25(19):10338. doi: 10.3390/ijms251910338.
9
BRD4: an effective target for organ fibrosis.BRD4:器官纤维化的有效靶点。
Biomark Res. 2024 Aug 30;12(1):92. doi: 10.1186/s40364-024-00641-6.
10
A detailed overview of quercetin: implications for cell death and liver fibrosis mechanisms.槲皮素的详细概述:对细胞死亡和肝纤维化机制的影响
Front Pharmacol. 2024 May 23;15:1389179. doi: 10.3389/fphar.2024.1389179. eCollection 2024.
Immunology in the liver--from homeostasis to disease.
肝脏中的免疫学——从稳态到疾病。
Nat Rev Gastroenterol Hepatol. 2016 Feb;13(2):88-110. doi: 10.1038/nrgastro.2015.200. Epub 2016 Jan 13.
4
BRD4 is a novel therapeutic target for liver fibrosis.BRD4是肝纤维化的一个新型治疗靶点。
Proc Natl Acad Sci U S A. 2015 Dec 22;112(51):15713-8. doi: 10.1073/pnas.1522163112. Epub 2015 Dec 7.
5
Hepatic fibrosis: Concept to treatment.肝纤维化:从概念到治疗。
J Hepatol. 2015 Apr;62(1 Suppl):S15-24. doi: 10.1016/j.jhep.2015.02.039.
6
Pathobiology of liver fibrosis: a translational success story.肝纤维化的病理生物学:一个转化医学的成功案例。
Gut. 2015 May;64(5):830-41. doi: 10.1136/gutjnl-2014-306842. Epub 2015 Feb 13.
7
Roles for chemokines in liver disease.趋化因子在肝脏疾病中的作用。
Gastroenterology. 2014 Sep;147(3):577-594.e1. doi: 10.1053/j.gastro.2014.06.043. Epub 2014 Jul 25.
8
Hepatic stellate cells and liver fibrosis.肝星状细胞与肝纤维化。
Compr Physiol. 2013 Oct;3(4):1473-92. doi: 10.1002/cphy.c120035.
9
CXCL6 antibody neutralization prevents lung inflammation and fibrosis in mice in the bleomycin model.CXCL6 抗体中和可预防博来霉素模型中小鼠的肺部炎症和纤维化。
J Leukoc Biol. 2013 Dec;94(6):1317-23. doi: 10.1189/jlb.0313140. Epub 2013 Aug 23.
10
Chemokine receptor CXCR6-dependent hepatic NK T Cell accumulation promotes inflammation and liver fibrosis.趋化因子受体 CXCR6 依赖性肝 NK T 细胞积累促进炎症和肝纤维化。
J Immunol. 2013 May 15;190(10):5226-36. doi: 10.4049/jimmunol.1202909. Epub 2013 Apr 17.